Safety of Dabigatran Etexilate in Blood Clot Prevention in Children
NCT02197416
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
214
Enrollment
INDUSTRY
Sponsor class
Conditions
Venous Thromboembolism
Secondary Prevention
Interventions
DRUG:
dabigatran etexilate
Sponsor
Boehringer Ingelheim